Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-11-19 2020-11-19
Drug Identification Number 02242069 02242069
Brand name TRILEPTAL 600 MG TRILEPTAL 600 MG
Common or Proper name TRILEPTAL FCT 600 MG 5 X 10 TRILEPTAL FCT 600 MG 5 X 10
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients OXCARBAZEPINE OXCARBAZEPINE
Strength(s) 600MG 600MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 5 X 10 5 X 10
ATC code N03AF N03AF
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-11-06 2020-11-06
Actual start date
Estimated end date 2020-11-16 2020-11-16
Actual end date 2020-11-19 2020-11-19
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Demand increase due to generic backorder. Limited stock available being allocated based on customer profile. Demand increase due to generic backorder. Limited stock available being allocated based on customer profile.
Health Canada comments